408 related articles for article (PubMed ID: 27756190)
1. Comparison of sensory tests and neuronal quantity of peripheral nerves between streptozotocin (STZ)-induced diabetic rats and paclitaxel (PAC)-treated rats.
Jin HY; Lee NY; Ko HA; Lee KA; Park TS
Somatosens Mot Res; 2016; 33(3-4):186-195. PubMed ID: 27756190
[TBL] [Abstract][Full Text] [Related]
2. Comparison of peripheral nerve protection between insulin-based glucose control and alpha lipoic acid (ALA) in the streptozotocin (STZ)-induced diabetic rat.
Lee KA; Lee NY; Park TS; Jin HY
Endocrine; 2018 Jul; 61(1):58-67. PubMed ID: 29736880
[TBL] [Abstract][Full Text] [Related]
3. Metformin Preserves Peripheral Nerve Damage with Comparable Effects to Alpha Lipoic Acid in Streptozotocin/High-Fat Diet Induced Diabetic Rats.
Kim SH; Park TS; Jin HY
Diabetes Metab J; 2020 Dec; 44(6):842-853. PubMed ID: 32602278
[TBL] [Abstract][Full Text] [Related]
4. The neuroprotective benefit from pioglitazone (PIO) addition on the alpha lipoic acid (ALA)-based treatment in experimental diabetic rats.
Jin HY; Lee KA; Wu JZ; Baek HS; Park TS
Endocrine; 2014 Dec; 47(3):772-82. PubMed ID: 24532138
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of Gelsemium-based treatment against paclitaxel-induced painful symptoms.
Vitet L; Patte-Mensah C; Boujedaini N; Mensah-Nyagan AG; Meyer L
Neurol Sci; 2018 Dec; 39(12):2183-2196. PubMed ID: 30251080
[TBL] [Abstract][Full Text] [Related]
6. Sulodexide prevents peripheral nerve damage in streptozotocin induced diabetic rats.
Jin HY; Lee KA; Song SK; Liu WJ; Choi JH; Song CH; Baek HS; Park TS
Eur J Pharmacol; 2012 Jan; 674(2-3):217-26. PubMed ID: 21641343
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions targeting Wnt/β-catenin signaling pathway attenuate paclitaxel-induced peripheral neuropathy.
Resham K; Sharma SS
Eur J Pharmacol; 2019 Dec; 864():172714. PubMed ID: 31586636
[TBL] [Abstract][Full Text] [Related]
8. Mechanical hyperalgesia correlates with insulin deficiency in normoglycemic streptozotocin-treated rats.
Romanovsky D; Cruz NF; Dienel GA; Dobretsov M
Neurobiol Dis; 2006 Nov; 24(2):384-94. PubMed ID: 16935517
[TBL] [Abstract][Full Text] [Related]
9. Early changes in insulin receptor signaling and pain sensation in streptozotocin-induced diabetic neuropathy in rats.
Sugimoto K; Rashid IB; Shoji M; Suda T; Yasujima M
J Pain; 2008 Mar; 9(3):237-45. PubMed ID: 18331706
[TBL] [Abstract][Full Text] [Related]
10. Neurosteroid 3α-androstanediol efficiently counteracts paclitaxel-induced peripheral neuropathy and painful symptoms.
Meyer L; Patte-Mensah C; Taleb O; Mensah-Nyagan AG
PLoS One; 2013; 8(11):e80915. PubMed ID: 24260511
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel therapy potentiates cold hyperalgesia in streptozotocin-induced diabetic rats through enhanced mitochondrial reactive oxygen species production and TRPA1 sensitization.
Barrière DA; Rieusset J; Chanteranne D; Busserolles J; Chauvin MA; Chapuis L; Salles J; Dubray C; Morio B
Pain; 2012 Mar; 153(3):553-561. PubMed ID: 22177224
[TBL] [Abstract][Full Text] [Related]
12. GLP‑1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF‑κB signaling pathways in streptozotocin‑induced diabetic rats.
Ma J; Shi M; Zhang X; Liu X; Chen J; Zhang R; Wang X; Zhang H
Int J Mol Med; 2018 May; 41(5):2977-2985. PubMed ID: 29484377
[TBL] [Abstract][Full Text] [Related]
13. The protective effects of DA-9801 (Dioscorea extract) on the peripheral nerves in streptozotocin-induced diabetic rats.
Lee KA; Jin HY; Baek HS; Park TS
J Nutr Sci Vitaminol (Tokyo); 2013; 59(5):437-46. PubMed ID: 24418878
[TBL] [Abstract][Full Text] [Related]
14. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
Davidson EP; Holmes A; Coppey LJ; Yorek MA
Eur J Pharmacol; 2015 Oct; 765():258-67. PubMed ID: 26291662
[TBL] [Abstract][Full Text] [Related]
15. Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation.
Lauria G; Lombardi R; Borgna M; Penza P; Bianchi R; Savino C; Canta A; Nicolini G; Marmiroli P; Cavaletti G
J Peripher Nerv Syst; 2005 Jun; 10(2):202-8. PubMed ID: 15958131
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of 15 Hz pulsed electromagnetic field on diabetic peripheral neuropathy in streptozotocin-treated rats.
Lei T; Jing D; Xie K; Jiang M; Li F; Cai J; Wu X; Tang C; Xu Q; Liu J; Guo W; Shen G; Luo E
PLoS One; 2013; 8(4):e61414. PubMed ID: 23637830
[TBL] [Abstract][Full Text] [Related]
17. Comparison of peripheral nerve damages according to glucose control timing in experimental diabetes.
Jin HY; Kang SM; Liu WJ; Song CH; Lee KA; Baek HS; Park TS
Exp Clin Endocrinol Diabetes; 2012 Sep; 120(8):451-9. PubMed ID: 22689102
[TBL] [Abstract][Full Text] [Related]
18. Stable Rat Model of Mechanical Allodynia in Diabetic Peripheral Neuropathy: The Role of Nerve Compression.
Liao C; Yang M; Liu P; Zhong W; Zhang W
J Reconstr Microsurg; 2018 May; 34(4):264-269. PubMed ID: 29396983
[TBL] [Abstract][Full Text] [Related]
19. Escin alleviates peripheral neuropathy in streptozotocin induced diabetes in rats.
Suryavanshi SV; Kulkarni YA
Life Sci; 2020 Aug; 254():117777. PubMed ID: 32407839
[TBL] [Abstract][Full Text] [Related]
20. Skin denervation, neuropathology, and neuropathic pain in a laser-induced focal neuropathy.
Chiang HY; Chen CT; Chien HF; Hsieh ST
Neurobiol Dis; 2005 Feb; 18(1):40-53. PubMed ID: 15649695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
